Literature DB >> 28112975

Complications of Uveitis: The Northern California Epidemiology of Uveitis Study.

David C Gritz1,2,3,4, Eric J Schwaber5, Ira G Wong1,2,6.   

Abstract

PURPOSE: To describe the uveitis complications in a large, community-based cohort.
METHODS: Retrospective, community-based, cross-sectional cohort study analyzing complications and associations with complications.
RESULTS: A total of 844 cases of uveitis were found; 342 were new-onset, and 462 were prior-onset. In total, 29.5% of patients were affected by one or more complications associated with age, gender, course, and anatomic location of uveitis. Visual loss was experienced by 19.1% of patients and was associated with age, course of disease, and anatomic location of uveitis. Of the patients who developed glaucoma or elevated intraocular pressure over 30 mmHg, 3.9% (n = 33) were related solely to uveitis; 5.2% (n = 44) had an unclear or combined mechanism; and 1.8% (n = 15) were related solely to steroid response. Cystoid macular edema was associated with course of disease and anatomic location of uveitis.
CONCLUSIONS: Complications affect a significant portion of uveitis patients, and are often associated with demographic and clinical factors.

Entities:  

Keywords:  Complications; epidemiology; glaucoma; steroid-response; uveitis

Mesh:

Year:  2017        PMID: 28112975     DOI: 10.1080/09273948.2016.1247174

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  9 in total

Review 1.  [Pharmacological treatment strategies and surgical options for uveitis].

Authors:  Justus G Garweg
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

2.  Intravitreal injection versus systematic treatment in patients with uveitis undergoing cataract surgery: a systematic review and meta-analysis.

Authors:  Yun-Hsiu Hsieh; Hong-Jie Jhou; Po-Huang Chen; Yih-Shiou Hwang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-22       Impact factor: 3.535

3.  Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.

Authors:  Kongnara Papangkorn; Eri Prendergast; John W Higuchi; Balbir Brar; William I Higuchi
Journal:  J Ocul Pharmacol Ther       Date:  2017-10-12       Impact factor: 2.671

4.  Classification Criteria for Birdshot Chorioretinitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-15       Impact factor: 5.488

5.  Classification Criteria for Herpes Simplex Virus Anterior Uveitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-09       Impact factor: 5.488

6.  Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort.

Authors:  Guillaume Morelle; Julie Gueudry; Florence Uettwiller; Carine Wouters; Brigitte Bader-Meunier; Mathieu P Robert; Dominique Monnet; Bahram Bodaghi; Martine Grall-Lerosey; Pierre Quartier
Journal:  RMD Open       Date:  2019-08-05

Review 7.  Recent Developments in HLA B27 Anterior Uveitis.

Authors:  Denis Wakefield; Daniel Clarke; Peter McCluskey
Journal:  Front Immunol       Date:  2021-01-05       Impact factor: 7.561

8.  Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study.

Authors:  Maria D Pinazo-Durán; Jose J García-Medina; Silvia M Sanz-González; Jose E O'Connor; Ricardo P Casaroli-Marano; Mar Valero-Velló; Maribel López-Gálvez; Cristina Peris-Martínez; Vicente Zanón-Moreno; Manuel Diaz-Llopis
Journal:  Diagnostics (Basel)       Date:  2021-04-19

9.  A Novel Clinical Five-Risk Factor Panel for Individualized Recurrence Risk Assessment of Patients With Acute Anterior Uveitis.

Authors:  Xiwen Ji; Zicheng Zhang; Dan Lin; Mali Dai; Xia Zhao; Xingneng Guo; Jie Du; Meng Zhou; Yuqin Wang
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.